To view links or images in this forum your post count must be 10 or greater. You currently have 0 posts.
The underlying principle of the new therapy is inducing cell death in the abnormal cells through the use of sphingolipids, a family of complex lipid molecules involved in the signaling pathways that mediate cell growth, differentiation and programmed cell death (apoptosis). This means, in layman's terms, that the next generation of cancer drugs could reach the long sought-after goal of forcing rogue cells to die.
Reply With Quote
Bookmarks